Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;69(12):2075-89.
doi: 10.1007/s00018-011-0913-1. Epub 2012 Jan 20.

Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments

Affiliations

Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments

Kristiina Uusi-Rauva et al. Cell Mol Life Sci. 2012 Jun.

Abstract

CLN3 is an endosomal/lysosomal transmembrane protein mutated in classical juvenile onset neuronal ceroid lipofuscinosis, a fatal inherited neurodegenerative lysosomal storage disorder. The function of CLN3 in endosomal/lysosomal events has remained elusive due to poor understanding of its interactions in these compartments. It has previously been shown that the localisation of late endosomal/lysosomal compartments is disturbed in cells expressing the most common disease-associated CLN3 mutant, CLN3∆ex7-8 (c.462-677del). We report here that a protracted disease causing mutant, CLN3E295K, affects the properties of late endocytic compartments, since over-expression of the CLN3E295K mutant protein in HeLa cells induced relocalisation of Rab7 and a perinuclear clustering of late endosomes/lysosomes. In addition to the previously reported disturbances in the endocytic pathway, we now show that the anterograde transport of late endosomal/lysosomal compartments is affected in CLN3 deficiency. CLN3 interacted with motor components driving both plus and minus end microtubular trafficking: tubulin, dynactin, dynein and kinesin-2. Most importantly, CLN3 was found to interact directly with active, guanosine-5'-triphosphate (GTP)-bound Rab7 and with the Rab7-interacting lysosomal protein (RILP) that anchors the dynein motor. The data presented in this study provide novel insights into the role of CLN3 in late endosomal/lysosomal membrane transport.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
ai The CLN3E295K mutant clusters late endosomes/lysosomes in a perinuclear region. Wild-type CLN3 (a) and the CLN3E295K mutant (d, g) were separately expressed in HeLa cells and analysed with endosomal/lysosomal markers by immunofluorescence microscopy. Contrary to the cells expressing wild-type CLN3 (b), expression of CLN3E295K induced a perinuclear clustering of LAMP-1-positive late endosomes and lysosomes (e), with no obvious effect on early endosomal EEA1-positive compartments (h). c, f and i represent the overlays of the immunofluorescence signals of indicated proteins. Scale bars 20 μm
Fig. 2
Fig. 2
am CLN3E295K affects compartmentalisation of EGFP-Rab7. HeLa cells transfected with EGFP-tagged Rab7 alone (a–c) or together with either wild-type CLN3 (dh) or the CLN3E295K mutant (im) were processed for CLN3, CLN3E295K, EGFP-Rab7 and LAMP-1 immunofluorescence microscopy. Compared to the other conditions, EGFP-Rab7 in the CLN3E295K-transfected cells appeared to be more concentrated on CLN3E295K (l) and LAMP-1-positive (m) compartments. c′, g′, h′, l′ and m′ represent magnifications of co-localisation area in the corresponding images. Scale bars 20 μm
Fig. 3
Fig. 3
Quantification of the co-localisation between CLN3 and EGFP-Rab7, and EGFP-Rab7 and LAMP-1. To quantify the results visualised in Fig. 2, immunofluorescence images of HeLa cells tranfected for EGFP-Rab7 alone, CLN3 and EGFP-Rab7, or CLN3E295K and EGFP-Rab7 were analysed by measuring Pearson’s correlation value for co-localisation between indicated immunofluorescence stainings. Each data point represents mean ± SEM of 15 cells of one experiment. *P < 0.0005 (one-tailed Student’s t test)
Fig. 4
Fig. 4
The CLN3E295K-induced perinuclear clustering of lysosomes is dependent on intact microtubules and functional dynactin complex. HeLa cells expressing CLN3E295K were either treated with nocodazole (upper panel) or co-expressed with EGFP-p50dynamitin (lower panel) and processed for CLN3 and LAMP-1 immunofluorescence microscopy. In both cases, CLN3E295K and LAMP-1-positive perinuclear clusters were lost and instead, corresponding compartments were dispersed throughout the cytoplasm. Scale bars 10 μm
Fig. 5
Fig. 5
a, b Cytoplasmic acidification-driven outward movement of LAMP-1-positive late endosomes and lysosomes is defective in CLN3-silenced HeLa cells. CLN3 siRNA and control siRNA-transfected Hela cells were treated with Ringer’s solution pH 7.2 or with Ringer’s solution pH 6.9 and processed for LAMP-1 immunofluorescence microscopy. a Each analysed cell was classified in one of the three phenotypic categories based on the distribution of LAMP-1 immunofluorescence staining; normal, dispersed and extremely dispersed. b The percentage of each phenotype per condition is indicated. Microscopy analyses were carried single-blindly. Each data point represents mean ± SEM of two individual experiments, and at least 150 cells were scored for each condition in each experiment. *P < 0.04, **P = 0.066 (one-tailed Student’s t test). Scale bar 20 μm
Fig. 6
Fig. 6
CLN3 interacts with both minus and plus end-directed motor protein components. COS-1 cells transfected with or without CLN3 (untransfected cell control) were processed for immunoprecipitation with anti-CLN3 242–258 followed by western blotting analysis with antibodies against components of microtubular motor complexes: β-tubulin (55 kDa), p150 Glued (150 kDa), dynein intermediate chain (DIC, 74 kDa) and KIF3A subunit of the heterotrimeric kinesin-2 complex (80/85 kDa). All tested proteins co-immunoprecipitated specifically with CLN3 (43 kDa). Matrix control represents sample devoid of precipitating antibody. Load represents 2% of total protein present in immunoprecipitation
Fig. 7
Fig. 7
a, b Xpress-Rab7 and Xpress-RILP co-immunoprecipitate with CLN3. COS-1 cells transfected for Xpress-tagged Rab7 (a) or Xpress-tagged RILP (b) with or without CLN3 were processed for immunoprecipitation with anti-CLN3 242–258 followed by western blotting with anti-Xpress and anti-CLN3. Both Xpress-Rab7 (~30 kDa) (a) and Xpress-RILP (~60 kDa) (b) co-immunoprecipitated only from the cells that also expressed CLN3 (43 kDa). Matrix control represents sample devoid of precipitating antibody. Load represents 2% of total protein present in immunoprecipitation
Fig. 8
Fig. 8
a, b CLN3 interacts directly with active, GTP-bound Rab7 and RILP via different cytoplasmic domains. a Mammalian two-hybrid experiment with two cytoplasmic CLN3 domains and different nucleotide-bound forms of Rab7, a wild-type Rab7, a GTPase-deficient constitutively active Rab7Q67L mutant, and a dominant-negative Rab7T22N mutant. Only CLN3 1–40/Rab7wt and 1–40/Rab7Q67L two-hybrids resulted in higher CAT expression than the corresponding controls. Each data point represents mean of normalised expression levels of CAT reporter gene of three individual experiments ±sem (one experiment contained CLN3 + Rab7 hybrids only). *P < 0.05 and **P = 0.11 (one-tailed Student’s t test). b GST (control) or GST-tagged domains of CLN3, the N-terminus (amino acids 1–33) and cytoplasmic loop (232–280) purified by coupling to glutathione Sepharose were incubated with purified His6-tagged Rab7Q67L and/or RILP recombinant proteins. Figure shows the results of the subsequent western blot analyses with Rab7 and RILP specific antibodies. His6-Rab7Q67L (~23 kDa) was found to directly interact with the N-terminal domain of CLN3. His6-RILP (~55 kDa) interacts directly with the cytoplasmic loop of CLN3. Load represents the percentage of total protein used
Fig. 9
Fig. 9
a, b Loss of lysosomal CLN3 impairs the GTP/GDP cycle of Rab7. a To assess the possible effects of CLN3 deficiency on the GTP/GDP cycle of Rab7, fibroblasts from healthy control and from two juvenile CLN3 disease patients, carrying CLN3∆ex7-8/CLN3∆ex7-8 (homozygous) or CLN3E295K/CLN3∆ex7-8 (compound heterozygous) mutations, were transfected with EGFP-Rab7. The EGFP fluorescence of late endosomal/lysosomal compartments was bleached, and fluorescence recovery (shown relative to the starting value, y-axis) as a function of time (x-axis) was recorded. CLN3∆ex7-8 homozygous cells showed accelerated recovery rates of EGFP-Rab7 signal. Each data point represents mean ± SEM of five recordings from different cells. b Immunofluorescence images of different time points of recovering cells (shown for control and homozygous CLN3∆ex7-8/CLN3∆ex7-8 cells). The bleached area is depicted by a square. N indicates the nucleus

References

    1. Phillips SN, Benedict JW, Weimer JM, Pearce DA. CLN3, the protein associated with batten disease: structure, function and localization. J Neurosci Res. 2005;79(5):573–583. doi: 10.1002/jnr.20367. - DOI - PubMed
    1. Jarvela I, Lehtovirta M, Tikkanen R, Kyttala A, Jalanko A. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL) Hum Mol Genet. 1999;8(6):1091–1098. doi: 10.1093/hmg/8.6.1091. - DOI - PubMed
    1. Fossale E, Wolf P, Espinola JA, Lubicz-Nawrocka T, Teed AM, Gao H, Rigamonti D, Cattaneo E, Macdonald ME, Cotman SL. Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis. BMC Neurosci. 2004;5(1):57. doi: 10.1186/1471-2202-5-57. - DOI - PMC - PubMed
    1. Kyttala A, Ihrke G, Vesa J, Schell MJ, Luzio JP. Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells. Mol Biol Cell. 2004;15(3):1313–1323. doi: 10.1091/mbc.E03-02-0120. - DOI - PMC - PubMed
    1. Luiro K, Kopra O, Lehtovirta M, Jalanko A. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum Mol Genet. 2001;10(19):2123–2131. doi: 10.1093/hmg/10.19.2123. - DOI - PubMed

Publication types

MeSH terms